Position in ASND
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,374,460
-$27,239 QoQ
Shares Held
19,125
-7.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#104
of 265 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atika Capital Management LLC holds $86,900,565 across 13 Biotechnology names. ASND ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
300,000 | $15,815,999 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
293,200 | $11,285,267 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
229,900 | $11,276,594 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
128,800 | $10,808,895 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
62,100 | $6,545,339 | |
| 6 | IMNM |
Immunome Inc.
|
262,900 | $5,749,622 | |
| 7 | DBVT |
DBV Technologies S.A.
|
271,300 | $5,667,456 | |
| 8 | ASND |
Ascendis Pharma A/S
This page
|
19,125 | $4,374,460 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,374,460 | 19,125 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,401,699 | 20,642 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,405,629 | 22,160 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,830,639 | 16,400 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,486,271 | 35,200 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $6,420,328 | 43,000 | Shares | Defined | 2024-11-13 | |
| 2024-03-31 | $7,331,743 | 48,500 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||